STAAR Surgical Company
NASDAQ:STAA
Overview | Financials
Company Name | STAAR Surgical Company |
Symbol | STAA |
Currency | USD |
Price | 31.46 |
Market Cap | 1,550,219,814 |
Dividend Yield | 0% |
52-week-range | 26.66 - 52.68 |
Industry | Medical Instruments & Supplies |
Sector | Healthcare |
CEO | Mr. Thomas G. Frinzi |
Website | https://www.staar.com |
An error occurred while fetching data.
About STAAR Surgical Company
STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and companion delivery systems to deliver the lenses into the eye. The company provides Visian implantable Collamer lens product family (ICLs) to treat visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia;
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD